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The New Zealand rare donor program
D. Gounder
Review
The New Zealand rare donor program was formally 
established in 1986—the same year that the International 
Society of Blood Transfusion (ISBT) Working Party on Rare 
Blood Donors was formed.1 Prior to this (since the mid-1970s), 
frozen blood units with rare blood types were maintained. 
These units would have been mainly for national use. More 
recently, the rare donor inventory of active donors has been 
updated to record the extended phenotype of individual 
donors.
Important aspects of the program
Presently, we have 69 active donors, of whom 34 are 
Jk(a–b–) (Table 1). Between 2012 and 2014, 15 new donors 
were added—the majority being Jk(a–b–). In the same period 
we shipped 17 Jk(a–b–) liquid units to Australia, most of 
which were needed for a single patient. We actively manage our 
frozen red cell inventory to ensure that we can maintain target 
numbers for the rare types considered important. Because we 
still have units in storage that do not meet our current donor 
accreditation requirements, it has become necessary that these 
units be replaced. Although challenging at times, we continue 
to maintain an ability to fulfil Jk(a–b–) requests from within 
New Zealand and abroad. We have not identified any Rhnull 
donors in particular in New Zealand. 
Report of incompatible blood transfusions
We have had one case of delayed hemolytic transfusion 
reaction in a Polynesian patient who received an emergency 
transfusion of 6 units of Jk(a+b+) blood for bleeding from 
a gunshot injury. He was subsequently identified to have 
developed anti-Jk3 from a previous transfusion. He was 
changed to Jk(a–b–) blood. Two days later, there was laboratory 
evidence of a delayed hemolytic transfusion reaction with a 
mild drop in the hemoglobin level. The patient was discharged 
without any long-term clinical consequence.
Rare donor incentives
The major focus for New Zealand has been the Jk(a–b–) 
phenotype. More recently, the availability and supply of 
Jk(a–b–) blood has been a challenge for us with the need to 
ship blood to Australia from time to time. The majority of 
our Jk(a–b–) donors are of Polynesian descent. We continue 
to experience poor retention of these donors. There is little 
knowledge of local Polynesian and Maori blood donation 
attitudes and behaviors. A more targeted recruitment and 
retention program has been suggested, probably with focus 
on community responsibility systems. This program may be 
better suited to Polynesian and Maori communities.2 
References
 1. Woodfield G, Poole J, Nance ST, Daniels G. A review of the 
ISBT rare blood donor program. Immunohematology 2004;20: 
244–48.
 2. Glynn SA, Kleinman SH, Schreiber GB, et al. Motivations to 
donate blood: demographic comparisons. Transfusion 2002; 
42:216–25.
Table 1. Active rare donors in New Zealand
Phenotype Number of donors
Jk(a–b–) 34
k– 29
Lu(b–) 3
r´r´ 2
(Oh) Bombay 2
Vel– 1
Co(a–) 1
